SURG is trading at $0.38 (-6.36%) in pre-market, extending a sharp multi-day sell-off despite no fresh company-specific news or earnings releases.
- The stock is coming off significant losses in previous sessions, having closed down -11.08% on July 7 and -19.50% on July 6.
- Selling pressure appears amplified by broader risk-off sentiment, with U.S. futures and major indices weakening and putting pressure on volatile small-cap names.
- SURG continues to exhibit high volatility and elevated price swings, with no immediate fundamental catalyst identified for the current move.